Dulaglutide · source year

Dulaglutide research records in 2020

6 selected, source-linked Dulaglutide records carrying a 2020 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

6 selected records.

Evidence types

2 represented types.

Cited sources

6 distinct public records.

Explore 2020 by evidence type

2 types

Cited chronology

Dulaglutide records dated 2020

Open in the filterable feed →

November 2020

1 record

Literature metadata

A CASE OF MORBILLIFORM DRUG ERUPTION TO DULAGLUTIDE.

PubMed lists PMID 33144906 in The Journal of clinical and aesthetic dermatology as Journal Article, with publication-date metadata of 2020-04-01 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

September 2020

1 record

May 2020

2 records

Literature metadata

Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).

PubMed lists PMID 30762290 in Diabetes, obesity & metabolism as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-03-29 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

March 2020

1 record

January 2020

1 record